Lite Strategy Stock (NASDAQ:LITS)
Previous Close
$2.56
52W Range
$1.46 - $9.00
50D Avg
$4.09
200D Avg
$2.94
Market Cap
$96.27M
Avg Vol (3M)
$1.69M
Beta
0.20
Div Yield
-
LITS Company Profile
Lite Strategy, Inc. a clinical-stage pharmaceutical company, focuses on the development of novel and differentiated therapies for the treatment of cancer. The company was formerly known as MEI Pharma, Inc. and changed its name to Lite Strategy, Inc. in September 2025. Lite Strategy, Inc. was incorporated in 2000 and is based in San Diego, California.